214 related articles for article (PubMed ID: 38165157)
1. Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress Responses.
Napoli M; Deshpande AA; Chakravarti D; Rajapakshe K; Gunaratne PH; Coarfa C; Flores ER
Cancer Res Commun; 2024 Feb; 4(2):264-278. PubMed ID: 38165157
[TBL] [Abstract][Full Text] [Related]
2. TAp63 and DeltaNp63 in cancer and epidermal development.
Candi E; Dinsdale D; Rufini A; Salomoni P; Knight RA; Mueller M; Krammer PH; Melino G
Cell Cycle; 2007 Feb; 6(3):274-85. PubMed ID: 17264681
[TBL] [Abstract][Full Text] [Related]
3. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
[TBL] [Abstract][Full Text] [Related]
4. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.
Nekulova M; Holcakova J; Nenutil R; Stratmann R; Bouchalova P; Müller P; Mouková L; Coates PJ; Vojtesek B
Virchows Arch; 2013 Sep; 463(3):415-25. PubMed ID: 23887585
[TBL] [Abstract][Full Text] [Related]
5. Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.
Abbas HA; Bui NHB; Rajapakshe K; Wong J; Gunaratne P; Tsai KY; Coarfa C; Flores ER
Cancer Res; 2018 Jan; 78(2):451-462. PubMed ID: 29180475
[TBL] [Abstract][Full Text] [Related]
6. DNA Demethylation Switches Oncogenic ΔNp63 to Tumor Suppressive TAp63 in Squamous Cell Carcinoma.
Pokorna Z; Hrabal V; Tichy V; Vojtesek B; Coates PJ
Front Oncol; 2022; 12():924354. PubMed ID: 35912167
[TBL] [Abstract][Full Text] [Related]
7. ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation.
Romano RA; Smalley K; Magraw C; Serna VA; Kurita T; Raghavan S; Sinha S
Development; 2012 Feb; 139(4):772-82. PubMed ID: 22274697
[TBL] [Abstract][Full Text] [Related]
8. [The two faces of p63, Janus of the p53 gene family].
Caron de Fromentel C; Aberdam E; Aberdam D
Med Sci (Paris); 2012 Apr; 28(4):381-7. PubMed ID: 22549865
[TBL] [Abstract][Full Text] [Related]
9. The foggy world(s) of p63 isoform regulation in normal cells and cancer.
Pokorná Z; Vysloužil J; Hrabal V; Vojtěšek B; Coates PJ
J Pathol; 2021 Jul; 254(4):454-473. PubMed ID: 33638205
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
[TBL] [Abstract][Full Text] [Related]
11. Frequent alteration of p63 expression in human primary bladder carcinomas.
Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
[TBL] [Abstract][Full Text] [Related]
12. A global analysis of the complex landscape of isoforms and regulatory networks of p63 in human cells and tissues.
Sethi I; Romano RA; Gluck C; Smalley K; Vojtesek B; Buck MJ; Sinha S
BMC Genomics; 2015 Aug; 16():584. PubMed ID: 26251276
[TBL] [Abstract][Full Text] [Related]
13. Roles of p63 in epidermal development and tumorigenesis.
Yao JY; Chen JK
Biomed J; 2012; 35(6):457-63. PubMed ID: 23442358
[TBL] [Abstract][Full Text] [Related]
14. Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors.
Vakonaki E; Soulitzis N; Sifakis S; Papadogianni D; Koutroulakis D; Spandidos DA
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1271-8. PubMed ID: 22441934
[TBL] [Abstract][Full Text] [Related]
15. The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63.
Helton ES; Zhang J; Chen X
Oncogene; 2008 May; 27(20):2843-50. PubMed ID: 18037962
[TBL] [Abstract][Full Text] [Related]
16. ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma.
Katoh I; Tsukinoki K; Hata RI; Kurata SI
Neoplasia; 2023 Nov; 45():100938. PubMed ID: 37778252
[TBL] [Abstract][Full Text] [Related]
17. p63-related signaling at a glance.
Fisher ML; Balinth S; Mills AA
J Cell Sci; 2020 Sep; 133(17):. PubMed ID: 32917730
[TBL] [Abstract][Full Text] [Related]
18. An active role of the DeltaN isoform of p63 in regulating basal keratin genes K5 and K14 and directing epidermal cell fate.
Romano RA; Ortt K; Birkaya B; Smalley K; Sinha S
PLoS One; 2009 May; 4(5):e5623. PubMed ID: 19461998
[TBL] [Abstract][Full Text] [Related]
19. Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls.
Alkhayyat R; Abbas A; Quinn CM; Rakha EA
Histopathology; 2024 Apr; 84(5):723-741. PubMed ID: 38012539
[TBL] [Abstract][Full Text] [Related]
20. Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation.
Wu HH; Wang B; Armstrong SR; Abuetabh Y; Leng S; Roa WHY; Atfi A; Marchese A; Wilson B; Sergi C; Flores ER; Eisenstat DD; Leng RP
Nucleic Acids Res; 2021 Mar; 49(5):2740-2758. PubMed ID: 33619536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
